Cargando…
Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells
Ex vivo gene therapy (GT) is a promising treatment for inherited genetic diseases. An ideal transduction protocol should determine high gene marking in long-term self-renewing hematopoietic stem cells (HSCs), preserving their repopulation potential during in vitro manipulation. In the context of the...
Autores principales: | Poletti, Valentina, Montepeloso, Annita, Pellin, Danilo, Biffi, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618226/ https://www.ncbi.nlm.nih.gov/pubmed/37920236 http://dx.doi.org/10.1016/j.omtm.2023.101131 |
Ejemplares similares
-
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells
por: Capotondo, Alessia, et al.
Publicado: (2017) -
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors
por: Pellin, Danilo, et al.
Publicado: (2019) -
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy
por: Ungari, Silvia, et al.
Publicado: (2015) -
Prostaglandin E(2) Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells
por: Heffner, Garrett C., et al.
Publicado: (2018) -
Prostaglandin E2 Stimulates the Expansion of Regulatory Hematopoietic Stem and Progenitor Cells in Type 1 Diabetes
por: Ben Nasr, Moufida, et al.
Publicado: (2018)